Randomized Trial of Radiation Therapy With and Without Rituximab for Patients With Stage I II Follicular Lymphoma Grade I/II
Phase of Trial: Phase III
Latest Information Update: 11 Apr 2017
At a glance
- Drugs Rituximab (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 22 May 2013 Status changed from not yet recruiting to recruiting as reported by M.D. Anderson Cancer Center.
- 22 May 2013 New source identified and integrated (M.D. Anderson Cancer Center: 2011-0283).
- 23 Apr 2013 Planned initiation date changed from 1 Dec 2012 to 1 Aug 2013 as reported by ClinicalTrials.gov.